Search Results 1791-1800 of 21362 for anti-TNF drugs

  1. Gastric acid suppression medications increase risk for recurrence of Clostridium difficile infection - Mayo Clinic News Network

    C-diff is a bacterium that can cause symptoms ranging from diarrhea to life-threatening inflammation of the colon. The study is published in JAMA Internal ...

  2. Phenothiazine (Oral Route, Parenteral Route, Rectal Route) Description and Brand Names - Mayo Clinic

    Chlorpromazine is used also in the treatment of certain types of porphyria, and with other medicines in the treatment of tetanus. Phenothiazines may also be ...

  3. Acetylcysteine (Inhalation Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Mucomyst. Descriptions. Acetylcysteine is a ...

  4. Hodgkin lymphoma (Hodgkin disease) - Care at Mayo Clinic

    Mayo Clinic radiation oncologists plan and deliver radiation therapy safely using advances such as volumetric modulated arc therapy and proton therapy. These ...

  5. A Study to Test How Well Different Doses of BI 3706674 Are Tolerated by People With Advanced Cancer in the Stomach and Oesophagus - Mayo Clinic

    drug. 2. Previous anti-cancer hormonal treatment or anti-cancer immunotherapy within 2 weeks of the first administration of trial drug. 3. Previous treatment ...

  6. Teriparatide (Subcutaneous Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  7. Glofitamab-Gxbm (Intravenous Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Columvi. Descriptions. Glofitamab-gxbm injection is used to ...

  8. A Study of Mogamulizumab Combined with Nivolumab in Patients who have Locally Advanced or Metastatic Solid Tumors - Mayo Clinic

    Has any unresolved toxicity grade > 1 from previous anti-cancer therapy. Subject use of immunosuppressive medication within 14 days before the Cycle 1 Day 1:.

  9. Melanoma - Care at Mayo Clinic

    Advanced diagnosis and treatment. Mayo Clinic doctors have access to the latest in diagnostic methods and treatment innovations to improve care for people with ...

  10. Study of Sacituzumab Govitecan (IMMU-132) in Metastatic or Locally Advanced Unresectable Urothelial Cancer - Mayo Clinic

    Participation eligibility · Cisplatin ineligibility is defined as meeting one of the following criteria: · Anti PD-1/PD-L1 therapy administered as part of ...